Investing.com - OpGen (NASDAQ:OPGN) reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
OpGen announced earnings per share of $-0.300 on revenue of $448.71K. Analysts polled by Investing.com anticipated EPS of $-0.130 on revenue of $1.55M.
OpGen shares are down 53.92% from the beginning of the year, still down 89.43% from its 52 week high of $1.75 set on November 12, 2021.
OpGen follows other major Healthcare sector earnings this month
OpGen's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar